Altered regulation of β-like globin genes by a redesigned erythroid transcription factor

Deepa G. Manwani, Mariann Galdass, James J. Bieker

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: Targeted regulation of β-like globin genes was studied using designer zinc finger transcription factors containing the DNA binding domain of the red cell specific transcription factor erythroid Kruppel-like factor (EKLF) fused to repression domains. Methods: Globin gene expression was analyzed after introduction of the modified transcription factors into cell lines, embryonic stem cells and transgenic mice. Results: As would be predicted, when introduced transiently into cells these transcription factors were effective in repressing the adult β-globin promoter CACCC element, which is the natural target for EKLF. In murine erythroleukemia cells repression of the adult β-globin gene was accompanied by a reactivation of the endogenous embryonic βH1-globin gene. Studies in differentiated embryonic stem cells and transgenic mice confirmed the reactivation of embryonic gene expression during development. Conclusion: Our studies support a competition model for β-globin gene expression and underscore the importance of EKLF in the embryonic/fetal-to-adult globin switch. They also demonstrate the feasibility of designer zinc finger transcription factors in the study of transcriptional control mechanisms at the β-globin locus and as potential gene therapy agents for sickle cell disease and related hemoglobinopathies.

Original languageEnglish (US)
Pages (from-to)39-47
Number of pages9
JournalExperimental Hematology
Volume35
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Globins
Transcription Factors
Genes
Zinc Fingers
Embryonic Stem Cells
Gene Expression
Transgenic Mice
Hemoglobinopathies
Leukemia, Erythroblastic, Acute
Sickle Cell Anemia
Genetic Therapy
Cell Line
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Altered regulation of β-like globin genes by a redesigned erythroid transcription factor. / Manwani, Deepa G.; Galdass, Mariann; Bieker, James J.

In: Experimental Hematology, Vol. 35, No. 1, 01.2007, p. 39-47.

Research output: Contribution to journalArticle

@article{05488dd0ef624f70aba4abb8aed3ed8b,
title = "Altered regulation of β-like globin genes by a redesigned erythroid transcription factor",
abstract = "Objective: Targeted regulation of β-like globin genes was studied using designer zinc finger transcription factors containing the DNA binding domain of the red cell specific transcription factor erythroid Kruppel-like factor (EKLF) fused to repression domains. Methods: Globin gene expression was analyzed after introduction of the modified transcription factors into cell lines, embryonic stem cells and transgenic mice. Results: As would be predicted, when introduced transiently into cells these transcription factors were effective in repressing the adult β-globin promoter CACCC element, which is the natural target for EKLF. In murine erythroleukemia cells repression of the adult β-globin gene was accompanied by a reactivation of the endogenous embryonic βH1-globin gene. Studies in differentiated embryonic stem cells and transgenic mice confirmed the reactivation of embryonic gene expression during development. Conclusion: Our studies support a competition model for β-globin gene expression and underscore the importance of EKLF in the embryonic/fetal-to-adult globin switch. They also demonstrate the feasibility of designer zinc finger transcription factors in the study of transcriptional control mechanisms at the β-globin locus and as potential gene therapy agents for sickle cell disease and related hemoglobinopathies.",
author = "Manwani, {Deepa G.} and Mariann Galdass and Bieker, {James J.}",
year = "2007",
month = "1",
doi = "10.1016/j.exphem.2006.09.004",
language = "English (US)",
volume = "35",
pages = "39--47",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Altered regulation of β-like globin genes by a redesigned erythroid transcription factor

AU - Manwani, Deepa G.

AU - Galdass, Mariann

AU - Bieker, James J.

PY - 2007/1

Y1 - 2007/1

N2 - Objective: Targeted regulation of β-like globin genes was studied using designer zinc finger transcription factors containing the DNA binding domain of the red cell specific transcription factor erythroid Kruppel-like factor (EKLF) fused to repression domains. Methods: Globin gene expression was analyzed after introduction of the modified transcription factors into cell lines, embryonic stem cells and transgenic mice. Results: As would be predicted, when introduced transiently into cells these transcription factors were effective in repressing the adult β-globin promoter CACCC element, which is the natural target for EKLF. In murine erythroleukemia cells repression of the adult β-globin gene was accompanied by a reactivation of the endogenous embryonic βH1-globin gene. Studies in differentiated embryonic stem cells and transgenic mice confirmed the reactivation of embryonic gene expression during development. Conclusion: Our studies support a competition model for β-globin gene expression and underscore the importance of EKLF in the embryonic/fetal-to-adult globin switch. They also demonstrate the feasibility of designer zinc finger transcription factors in the study of transcriptional control mechanisms at the β-globin locus and as potential gene therapy agents for sickle cell disease and related hemoglobinopathies.

AB - Objective: Targeted regulation of β-like globin genes was studied using designer zinc finger transcription factors containing the DNA binding domain of the red cell specific transcription factor erythroid Kruppel-like factor (EKLF) fused to repression domains. Methods: Globin gene expression was analyzed after introduction of the modified transcription factors into cell lines, embryonic stem cells and transgenic mice. Results: As would be predicted, when introduced transiently into cells these transcription factors were effective in repressing the adult β-globin promoter CACCC element, which is the natural target for EKLF. In murine erythroleukemia cells repression of the adult β-globin gene was accompanied by a reactivation of the endogenous embryonic βH1-globin gene. Studies in differentiated embryonic stem cells and transgenic mice confirmed the reactivation of embryonic gene expression during development. Conclusion: Our studies support a competition model for β-globin gene expression and underscore the importance of EKLF in the embryonic/fetal-to-adult globin switch. They also demonstrate the feasibility of designer zinc finger transcription factors in the study of transcriptional control mechanisms at the β-globin locus and as potential gene therapy agents for sickle cell disease and related hemoglobinopathies.

UR - http://www.scopus.com/inward/record.url?scp=33845750149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845750149&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2006.09.004

DO - 10.1016/j.exphem.2006.09.004

M3 - Article

C2 - 17198872

AN - SCOPUS:33845750149

VL - 35

SP - 39

EP - 47

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 1

ER -